Cancer Biology & Medicine

Prof. Lieping Chen et al. published their work on immune suppressor Siglec-15 in Nature Medicine at the beginning of this year. According to this breakthrough research, Prof. Xiubao Ren accepted our invitation and contributed an editorial with perspective on a therapeutic application related to this new target. In this latest issue, you could appreciate Prof. Ren’s work and learn about his viewpoints.

Supporting by a large population study, Prof. Martha L. Slattery et al. composed a review which discusses the functional role of miRNAs and colorectal cancer. As for the results of original researches, including the molecular mechanisms in tumorigenesis or cancer development associated with signal pathways, the application of new drugs in cancer treatment, and so on, should be also useful and worthy of reading by oncologic clinicians and researchers.

We hope all of these articles will greatly benefit your research and clinical practice. Thank you for your attention and welcome to submit your work to Cancer Biology & Medicine.

The 1st issue in 2019 has been published. An editorial and a Chinese expert consensus offer the advances and insights in clinical application of next-generation sequencing. Another editorial reports a breakthrough in in vitro expansion of human primary hepatocytes. Review of Jianguo Chen et al. shows the epidemiological trend and risk factors of liver cancer in Qidong, an area with high incidence. What’s more, two original researches from China are worthy of recommending. One study on reactive capillary hemangiomas from Xuelian Chen et al. could arouse an awareness of drug toxicities in immunotherapy. Another one written by Xiaohong Wu et al. reports that BRAF mutation and TIRADS classification could be as tools in diagnosis of papillary thyroid cancer. Besides, several latest results from basic and clinical researches were also presented, especially studies on signaling pathways. We hope all of these articles will greatly benefit your research and clinical practice.

Thank you for your attention and welcome to submit your work to Cancer Biology & Medicine.

Click here to read all the full texts for free.